Errors in the Use of Turbuhaler and Spiromax Devices Patients With Asthma

Fundación Pública Andaluza Progreso y Salud

Status: Completed

Conditions: Asthma

Treatments: Device: SPIROMAX®; Device: TURBUHALER®

Study type: Observational

Funder types: Other

Identifiers

NCT02983994

FPS-INH-2016-01

Details and patient eligibility

About

The aim of the study is to evaluate the errors that may occur during inhalation of two devices in patients with asthma, as well as to study whether it relates to the degree of control of patient symptoms and the degree of compliance of medication symptoms. Finally, we also want to study the degree of patient satisfaction with each of the inhalers studied

Enrollment: 64 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of asthma with treatment indication with CI + LABA according to GINA 2015 guide and in dry powder device.
• Over 18 years.
• Patient in stable phase without having had exacerbations in the 3 months previous to the Inclusion in the study

Exclusion criteria

• Presence of relevant respiratory disease other than asthma (including COPD).
• Refusal to participate in the study and sign informed consent or inability to To give informed consent.
• Patients who have previously been treated with inhaled dust devices dry.

Trial design

64 participants in 2 patient groups

Patients with asthma with an inhaled steroid

Description:

Patients with a diagnosis of asthma with indication of Treatment with an inhaled steroid (CI)

Treatment:

Device: TURBUHALER®

Patients with asthma with an inhaled Beta agonist

Description:

Patients with a diagnosis of asthma with indication of Treatment with an inhaled Beta agonist (LABA)

Treatment:

Device: SPIROMAX®